VERVE THERAPEUTICS INC. - COMMON STOCK
8.5800
14-February-25 15:45:00
15 minutes delayed
Stocks
+0.8700
+11.28%
Today's range
7.8200 - 8.8700
ISIN
N/A
Source
NASDAQ
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Feb 2025 15:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
29 Jan 2025 06:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
13 Jan 2025 06:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08 Jan 2025 06:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Jan 2025 15:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
29 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
05 Nov 2024 06:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2024 15:26:49 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 Oct 2024 15:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
08 Aug 2024 06:00:01 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
28 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
31 May 2024 15:01:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Leadership Update
31 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
30 May 2024 15:01:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
08 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
07 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 May 2024 15:01:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >